Total Payments
$20,290
2024 Payments
$1,984
Companies
55
Transactions
1,070
Medicare Patients
19,983
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$19,647 (96.8%)
Travel$623.73 (3.1%)
Education$18.66 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,647 | 1,066 | 96.8% |
| Travel and Lodging | $623.73 | 2 | 3.1% |
| Education | $18.66 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,215 | 48 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,974 | 142 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,665 | 97 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,563 | 108 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,241 | 71 | $0 (2024) |
| Amgen Inc. | $1,235 | 81 | $0 (2024) |
| PFIZER INC. | $1,232 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,166 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $934.69 | 61 | $0 (2024) |
| Boston Scientific Corporation | $644.59 | 31 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,984 | 86 | E.R. Squibb & Sons, L.L.C. ($286.30) |
| 2023 | $2,451 | 123 | Novartis Pharmaceuticals Corporation ($331.68) |
| 2022 | $2,841 | 137 | Janssen Pharmaceuticals, Inc ($427.61) |
| 2021 | $2,739 | 158 | Janssen Pharmaceuticals, Inc ($374.26) |
| 2020 | $2,244 | 129 | Boston Scientific Corporation ($222.43) |
| 2019 | $2,045 | 134 | E.R. Squibb & Sons, L.L.C. ($297.73) |
| 2018 | $3,366 | 159 | Abbott Laboratories ($1,201) |
| 2017 | $2,619 | 144 | Abbott Laboratories ($307.91) |
All Payment Transactions
1,070 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $172.67 | General |
| Category: Lithoplasty | ||||||
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $26.59 | General |
| Category: Coronary | ||||||
| 11/22/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Genetic Disease | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.80 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/07/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Obesity | ||||||
| 10/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Cardiovascular | ||||||
| 10/25/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | BIOTRONIK INC. | PK Papyrus (Device) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.03 | General |
| Category: Cardiovascular | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.64 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 4,639 | 6,993 | $1.5M | $466,128 |
| 2022 | 32 | 5,253 | 7,845 | $1.5M | $507,374 |
| 2021 | 33 | 4,821 | 7,438 | $1.5M | $538,355 |
| 2020 | 37 | 5,270 | 7,920 | $1.6M | $532,005 |
Total Patients
19,983
Total Services
30,196
Medicare Billing
$2.0M
Procedure Codes
149
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 646 | 1,121 | $336,300 | $110,692 | 32.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 283 | 885 | $154,875 | $57,587 | 37.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 131 | 131 | $124,450 | $46,068 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 198 | 263 | $92,050 | $37,543 | 40.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 130 | 259 | $51,800 | $28,709 | 55.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 164 | 164 | $123,000 | $22,975 | 18.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 155 | 159 | $47,700 | $17,072 | 35.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 232 | 236 | $73,160 | $12,975 | 17.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 693 | 1,085 | $65,100 | $12,521 | 19.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 16 | 16 | $24,000 | $11,263 | 46.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 57 | 228 | $22,800 | $9,872 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 70 | $26,250 | $9,850 | 37.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 95 | $19,000 | $9,298 | 48.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 177 | 178 | $62,300 | $8,926 | 14.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,019 | 1,286 | $38,580 | $8,509 | 22.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 18 | 19 | $26,600 | $8,462 | 31.8% |
| 92941 | Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | Facility | 2023 | 14 | 15 | $23,250 | $8,201 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $18,550 | $7,149 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 58 | 87 | $26,100 | $6,963 | 26.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 36 | 36 | $25,200 | $6,260 | 24.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 34 | 34 | $15,300 | $4,955 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $9,600 | $4,359 | 45.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 46 | 135 | $6,750 | $3,034 | 44.9% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 11 | $4,950 | $2,418 | 48.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 45 | 132 | $6,600 | $2,306 | 34.9% |
About Dr. Fahd Jajeh, MD
Dr. Fahd Jajeh, MD is a Cardiovascular Disease healthcare provider based in Libertyville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558355255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fahd Jajeh, MD has received a total of $20,290 in payments from pharmaceutical and medical device companies, with $1,984 received in 2024. These payments were reported across 1,070 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($19,647).
As a Medicare-enrolled provider, Jajeh has provided services to 19,983 Medicare beneficiaries, totaling 30,196 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Libertyville, IL
- Active Since 09/08/2005
- Last Updated 12/22/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1558355255
Products in Payments
- ELIQUIS (Drug) $2,561
- XARELTO (Drug) $1,577
- LifeVest (Device) $1,241
- Asahi Fielder coronary guide wire (Device) $1,175
- ENTRESTO (Drug) $1,166
- Repatha (Biological) $738.49
- JARDIANCE (Drug) $652.17
- BRILINTA (Drug) $620.26
- Vascepa (Drug) $559.23
- Corlanor (Drug) $496.69
- PRADAXA (Drug) $484.24
- Impella (Device) $483.56
- ONPATTRO (Drug) $457.07
- WATCHMAN (Device) $452.04
- NEXLETOL (Drug) $407.47
- LEQVIO (Drug) $396.89
- NORTHERA (Drug) $386.30
- CHANTIX (Drug) $334.80
- PRALUENT (Drug) $306.98
- CardioMEMS HF System (Device) $263.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Libertyville
Dr. Robert Koch, Do, DO
Cardiovascular Disease — Payments: $446,823
Cardiovascular Disease $446,823
Dr. Benjamin Rojas, D.o, D.O
Cardiovascular Disease — Payments: $20,087
Cardiovascular Disease $20,087
Maher Nahlawi, Md, MD
Cardiovascular Disease — Payments: $17,055
Cardiovascular Disease $17,055
Dr. Eric Kessler, M.d, M.D
Cardiovascular Disease — Payments: $12,926
Cardiovascular Disease $12,926
William Sanchez-Garcia, Md, MD
Cardiovascular Disease — Payments: $2,745
Cardiovascular Disease $2,745
Dr. Ray Helms, M.d, M.D
Cardiovascular Disease — Payments: $1,847
Cardiovascular Disease $1,847